Acetylsalicylic acid, hemostasis and human thromboembolism.
D000249:Adenosine Monophosphate / Q000096:biosynthesis; D001241:Aspirin / Q000494:pharmacology* / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects; D006328:Cardiac Catheterization; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D003165:Complement System Proteins; D003327:Coronary Disease / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D005342:Fibrinolysis / Q000187:drug effects; D006157:Guanosine Monophosphate / Q000096:biosynthesis; D006350:Heart Valve Prosthesis; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000096:biosynthesis; D013923:Thromboembolism / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control*
D011453:Prostaglandins; D000249:Adenosine Monophosphate; D006157:Guanosine Monophosphate; D003165:Complement System Proteins; D001241:Aspirin